X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse SUVEN LIFE with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFESCIENCES   ACTAVIS
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
ACTAVIS
Dec-18
SUVEN LIFESCIENCES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs33813,872-   
Low Rs1699,305-   
Sales per share (Unadj.) Rs52.13,402.8-  
Earnings per share (Unadj.) Rs6.8-1,096.0-  
Cash flow per share (Unadj.) Rs8.6358.6-  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs65.314,034.9-  
Shares outstanding (eoy) m127.28332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.93.4 142.8%   
Avg P/E ratio x37.1-10.6 -351.1%  
P/CF ratio (eoy) x29.632.3 91.5%  
Price / Book Value ratio x3.90.8 470.3%  
Dividend payout %22.00-   
Avg Mkt Cap Rs m32,2723,854,398 0.8%   
No. of employees `0001.116.9 6.4%   
Total wages/salary Rs m6610-   
Avg. sales/employee Rs Th6,132.266,968.6 9.2%   
Avg. wages/employee Rs Th611.10-   
Avg. net profit/employee Rs Th803.5-21,570.6 -3.7%   
INCOME DATA
Net Sales Rs m6,6351,131,770 0.6%  
Other income Rs m24221,643 1.1%   
Total revenues Rs m6,8771,153,413 0.6%   
Gross profit Rs m1,60429,658 5.4%  
Depreciation Rs m221483,807 0.0%   
Interest Rs m3865,310 0.1%   
Profit before tax Rs m1,587-497,815 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0126,963 0.0%   
Tax Rs m718-6,309 -11.4%   
Profit after tax Rs m869-364,544 -0.2%  
Gross profit margin %24.22.6 922.6%  
Effective tax rate %45.21.3 3,569.1%   
Net profit margin %13.1-32.2 -40.7%  
BALANCE SHEET DATA
Current assets Rs m6,232464,193 1.3%   
Current liabilities Rs m1,490410,640 0.4%   
Net working cap to sales %71.54.7 1,510.5%  
Current ratio x4.21.1 370.0%  
Inventory Days Days8620 441.3%  
Debtors Days Days8366 124.6%  
Net fixed assets Rs m4,043128,110 3.2%   
Share capital Rs m1270-   
"Free" reserves Rs m8,1830-   
Net worth Rs m8,3104,668,023 0.2%   
Long term debt Rs m181,643,780 0.0%   
Total assets Rs m10,3897,297,182 0.1%  
Interest coverage x43.1-6.6 -650.9%   
Debt to equity ratio x00.4 0.6%  
Sales to assets ratio x0.60.2 411.8%   
Return on assets %8.7-4.1 -212.9%  
Return on equity %10.5-7.8 -134.0%  
Return on capital %19.5-4.8 -403.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,8220-   
CASH FLOW
From Operations Rs m356404,339 0.1%  
From Investments Rs m-279222,131 -0.1%  
From Financial Activity Rs m-225-693,966 0.0%  
Net Cashflow Rs m-148-67,159 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.69 Rs / USD

Compare SUVEN LIFESCIENCES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SUVEN LIFESCIENCES With: ABBOTT INDIA  FDC LTD.  BIOCON   SANOFI INDIA  PANACEA BIOTECH  



Today's Market

Of Falling Stocks, Tumbling Rupee and Weakening Economy(Podcast)

Another week of slowdown in the markets over fears of a looming slowdown in the domestic and global economy continue.

Related Views On News

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

More Views on News

Most Popular

This 60-Year Old Smallcap Company Could Be Our Next Recommendation (The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Interest Rates Are Low. Buy Solid Dividend Stocks Instead (The 5 Minute Wrapup)

Aug 13, 2019

The dividends paid by these stocks are helpful when interest rates are falling.

Smallcaps that Will Outperform in the Market Rebound (Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

My Top 3 Dividend Stocks to Buy Now (Profit Hunter)

Aug 19, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Chandrayaan 2 Heads to the Moon and It's Good News for These Stocks (The 5 Minute Wrapup)

Aug 14, 2019

Why investors should take note of India's advantage as a low cost satellite launcher...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Aug 23, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS